论文部分内容阅读
目的评价Ⅰ及Ⅱ期食管癌根治术后放射治疗的价值．方法收治103例术后病理确诊为Ⅰ～Ⅱ期的食管癌，单纯手术72例，加术后放疗31例，放射剂量50～60Gy．结果随访5年以上，47例复发，复发与TNM分期有关，区域淋巴结和食管瘤床失败与食管原发部位有显著关系。手术切除组：1、3、5年生存率分别为87．5％、69．4％、41．7％，术后放疗组1、3、5年生存率为90．3％、83．9％、74．2％。结论术后放疗复发率低，5年生存率术后放疗组明显高于单纯手术组。Ⅰ及Ⅱ期食管癌术后常规放疗可提高远期生存率。
Objective To evaluate the value of postoperative radiotherapy for the treatment of esophageal cancer in stage I and II. Methods 103 cases of pathologically diagnosed esophageal cancer with stage I-II were enrolled, 72 cases were treated with surgery alone, and 31 cases were treated with postoperative radiotherapy. The radiation dose was 50-60 Gy. Results The follow-up of more than 5 years showed that 47 cases had recurrence and recurrence was related to TNM staging. The failure of regional lymph node and esophageal tumor bed was significantly associated with the primary site of esophagus. In the surgical resection group, the 1-, 3-, and 5-year survival rates were 87.5%, 69.4%, and 41.7%, respectively. The 1, 3, and 5-year survival rates of the postoperative radiotherapy group were 90.3% and 83.9 respectively. %, 74.2%. Conclusions The recurrence rate of postoperative radiotherapy is low, and the 5-year survival rate is significantly higher in the postoperative radiotherapy group than in the simple surgery group. Postoperative routine radiotherapy for stage I and II esophageal cancer can improve long-term survival.